This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: Jo Slashedrgen Svensson: Innovator in Pharmaceutical Composition
Introduction
Jo Slashedrgen Svensson is a notable inventor based in Frederikssund, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work involving tiagabine hydrochloride. His dedication to research and development has led to the creation of a valuable patent that enhances therapeutic options for patients.
Latest Patents
Jo Svensson holds a patent for a pharmaceutical composition containing tiagabine hydrochloride. This invention is crucial in the treatment of certain medical conditions, showcasing his expertise and commitment to improving healthcare outcomes. He has 1 patent to his name, reflecting his innovative contributions to the pharmaceutical industry.
Career Highlights
Svensson is currently employed at Novo Nordisk A/S, a leading global healthcare company. His role at Novo Nordisk allows him to collaborate with other talented professionals in the field. His work is characterized by a focus on developing effective treatments that can significantly impact patient care.
Collaborations
Throughout his career, Jo has worked alongside esteemed colleagues such as Helle Weibel and Lars Nygaard. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Jo Slashedrgen Svensson is a distinguished inventor whose work in pharmaceutical compositions has the potential to improve the lives of many. His contributions to the field, particularly through his patent, highlight the importance of innovation in healthcare.